Wolverine Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wolverine Trading’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-54,360	Closed	-$92K	–	5834
2018 Q3	$92K	Buy	54,360 +29,884	+122%	+$53.5K	﹤0.01%	4569
2018 Q2	$45K	Hold	24,476	–	–	﹤0.01%	4922
2018 Q1	$45K	Sell	24,476 -6,429	-21%	-$13.6K	﹤0.01%	4922
2017 Q4	$69K	Buy	30,905 +2,804	+10%	+$6.97K	﹤0.01%	4549
2017 Q3	$81K	Sell	28,101 -4,665	-14%	-$15.9K	﹤0.01%	4132
2017 Q2	$143K	Buy	+32,766	New	+$135K	﹤0.01%	3774
2016 Q4	–	Sell	-17,467	Closed	-$91.3K	–	5546
2016 Q3	$93K	Sell	17,467 -69,999	-80%	-$328K	﹤0.01%	4221
2016 Q2	$327K	Buy	+87,466	New	+$296K	﹤0.01%	2692

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wolverine Trading's SGYP Position: Q4 2018 in Review

Wolverine Trading sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 54,360 shares — an estimated $92K sold.

Wolverine Trading first reported a position in SGYP in Q2 2016 and held it in 8 quarters. The position peaked at $327K in Q2 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Wolverine Trading reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Wolverine Trading sold 54,360 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $92K.
Wolverine Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 8 quarters.
Wolverine Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $327K in Q2 2016.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Wolverine Trading's 13F filing for Q4 2018, filed 14 Feb 2019.